Schedule 13D ownership disclosure

Vor BioPharma Inc

Common Stock, par value $.0001 per share · CUSIP: 929033207

Event date: 2025-10-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Reprogrammed Interchange LLCReported CIK 0002050755

    Shares: 1,204,442.00 · Class: 17.6%

  • Reid HoffmanReported CIK 0001519339

    Shares: 1,204,442.00 · Class: 17.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050755-25-000018
Form type
SCHEDULE 13D/A
Filer
Reprogrammed Interchange LLC
CIK
CIK 2050755
Filed
Oct 17, 2025
Reporting period
Oct 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub